- Home
- BMRN vs MANH Comparison
BMRN vs MANH Comparison
Compare BMRN & MANH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRN
- MANH
- Stock Information
- Founded
- BMRN 1996
- MANH 1990
- Country
- BMRN United States
- MANH United States
- Employees
- BMRN N/A
- MANH N/A
- Industry
- BMRN Biotechnology: Pharmaceutical Preparations
- MANH Computer Software: Prepackaged Software
- Sector
- BMRN Health Care
- MANH Technology
- Exchange
- BMRN Nasdaq
- MANH Nasdaq
- Market Cap
- BMRN 11.3B
- MANH 13.0B
- IPO Year
- BMRN 1999
- MANH 1998
- Fundamental
- Price
- BMRN $57.54
- MANH $214.79
- Analyst Decision
- BMRN Buy
- MANH Buy
- Analyst Count
- BMRN 23
- MANH 9
- Target Price
- BMRN $93.14
- MANH $221.25
- AVG Volume (30 Days)
- BMRN 2.5M
- MANH 687.7K
- Earning Date
- BMRN 08-04-2025
- MANH 07-22-2025
- Dividend Yield
- BMRN N/A
- MANH N/A
- EPS Growth
- BMRN 154.69
- MANH 9.17
- EPS
- BMRN 3.40
- MANH 3.58
- Revenue
- BMRN $3,063,608,000.00
- MANH $1,057,690,000.00
- Revenue This Year
- BMRN $12.34
- MANH $4.95
- Revenue Next Year
- BMRN $10.01
- MANH $6.76
- P/E Ratio
- BMRN $16.93
- MANH $59.99
- Revenue Growth
- BMRN 18.36
- MANH 6.13
- 52 Week Low
- BMRN $52.93
- MANH $140.81
- 52 Week High
- BMRN $94.85
- MANH $312.60
- Technical
- Relative Strength Index (RSI)
- BMRN 47.03
- MANH 54.12
- Support Level
- BMRN $56.45
- MANH $203.99
- Resistance Level
- BMRN $58.62
- MANH $220.72
- Average True Range (ATR)
- BMRN 1.95
- MANH 6.19
- MACD
- BMRN -0.25
- MANH -0.91
- Stochastic Oscillator
- BMRN 15.51
- MANH 42.20
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.
About MANH Manhattan Associates Inc.
Manhattan Associates provides software that helps users manage their supply chains, inventory, and omnichannel operations. Customers are generally retailers, wholesalers, manufacturers, and logistics providers. The company was founded in 1990 and serves more than 1,200 customers around the world.